Multiple effects of the special ATâ•'rich binding protein 1 (SATB1) in colon carcinoma
MedTech-2022 Conferences | MedTech -2022 | MedTech 2022 Events | Pharma Industry and MedTech | MedTech Conferences | MedTech Meetings | Pharma Industry and MedTech | | Pharma Industry and MedTech Congress
Module III – CAS in Radiopharmaceutical Chemistry/Radiopharmacy | ETH Zurich
Mitarbeiter des Rudolf-Boehm-Institutes
Achim AIGNER | University of Leipzig, Leipzig | Institute of Pharmacology, Pharmacy and Toxicology
Achim Aigner | Leipzig University, Germany | Pharmaceutica 2017 | Conferenceseries
Leipziger Pharmakologen forschen an Molekülen gegen Prostatakrebs
Targeted CRM197-PEG-PEI/siRNA Complexes for Therapeutic RNAi in Glioblastoma
SiRNA-transfection of SKOV-3-Luc cells with the Biontex K2® Transfection System Dipl.-Chem. Alexander Ewe, Prof. Achim Aigner U
Foresee Edebi sanatlar yelken achim aigner leipzig university germany Tren istasyonu ilgisiz yerine getirmek
Tetraspanin 5 (TSPAN5), a Novel Gatekeeper of the Tumor Suppressor DLC1 and Myocardin-Related Transcription Factors (MRTFs), Con
Therapeutic Targeting of Stat3 Using Lipopolyplex Nanoparticle-Formulated siRNA in a Syngeneic Orthotopic Mouse Glioma Model
Loop | Achim Aigner
Anti-tumor effects of fibroblast growth factor-binding protein (FGF-BP) knockdown in colon carcinoma – topic of research paper in Biological sciences. Download scholarly article PDF and read for free on CyberLeninka open science
Mitarbeiter des Rudolf-Boehm-Institutes
European Technology Platform on Nanomedicine
Exploring the MIR143-UPAR Axis for the Inhibition of Human Prostate Cancer Cells In Vitro and In Vivo
Nanoparticle-mediated delivery of small RNA molecules in tumor therapy
Achim AIGNER | University of Leipzig, Leipzig | Institute of Pharmacology, Pharmacy and Toxicology
Analysis of SATB1 in Head and Neck Squamous Cell Carcinoma
Mitarbeiter des Rudolf-Boehm-Institutes
PDF) The proto-oncogene Pim-1 is a target of miR-33a | Marshall Thomas - Academia.edu
Achim AIGNER | University of Leipzig, Leipzig | Institute of Pharmacology, Pharmacy and Toxicology
Perspectives, issues and solutions in RNAi therapy: the expected and the less expected
Let Life Sciences meet you Let Life Sciences meet you
